Outsourcing Formulation Services for Biologics: The pandemic and shifting focus to more complex therapeutics are driving growth in the outsourced formulation development services market.
| Publicado en: | Pharmaceutical Technology Europe Vol. 35; no. 9; pp. 30 - 33 |
|---|---|
| Autor principal: | |
| Formato: | pictorial Journal Article |
| Publicado: |
MJH Life Sciences
Sep2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=172011551&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 172011551 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17537967 5NG jtl: Pharmaceutical Technology Europe issn: 17537967 maglogo: N pubinfo: dt: Sep2023 vid: 35 iid: 9 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 172011551 172011551 172011551 172011551 ppf: 30 ppct: 3 formats: fmt: @attributes: type: P tig: atl: Outsourcing Formulation Services for Biologics: The pandemic and shifting focus to more complex therapeutics are driving growth in the outsourced formulation development services market. aug: au: Thomas, Felicity sug: subj: Chemistry, Pharmaceutical Contract Services Biological Products Business COVID-19 Pandemic Europe Pharmaceutical Companies Manufacturing Industry Technology, Pharmaceutical Europe pubtype: Trade Publication doctype: pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|